sulfalene has been researched along with Infections, Orthomyxoviridae in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fukushima, K; Kanazawa, H; Kawahara, T; Kawakami, T; Masuda, M; Oishi, K; Suzuki, T; Takahashi, S; Takahashi, T; Takano, M; Tanaka, H | 1 |
1 other study(ies) available for sulfalene and Infections, Orthomyxoviridae
Article | Year |
---|---|
Consecutive oral administration of Bifidobacterium longum MM-2 improves the defense system against influenza virus infection by enhancing natural killer cell activity in a murine model.
Topics: Administration, Oral; Animals; Bifidobacterium; Cytokines; Disease Models, Animal; Female; Gene Expression Profiling; Influenza A Virus, H1N1 Subtype; Killer Cells, Natural; Lung; Mice, Inbred BALB C; Orthomyxoviridae Infections; Probiotics; Spleen; Sulfalene; Survival Analysis | 2015 |